49 results on '"Song, Qiaoling"'
Search Results
2. A β-1,3/1,6-glucan enhances anti-tumor effects of PD1 antibody by reprogramming tumor microenvironment
3. Type I interferon signaling facilitates resolution of acute liver injury by priming macrophage polarization
4. Gp130-dependent STAT3 activation in M–CSF–derived macrophages exaggerates tumor progression
5. Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)
6. Transmissible ER stress between macrophages and tumor cells configures tumor microenvironment
7. Immunostimulatory and Immunoadjuvant Capacities of Soluble Rhamnan-Type Ulva Oligosaccharides
8. A virus-induced conformational switch of STAT1-STAT2 dimers boosts antiviral defenses
9. Short-term exposure to air pollution and occurrence of emergency stroke in Chongqing, China
10. Methanol steam reforming for hydrogen production over ternary composite ZnyCe1Zr9Ox catalysts
11. A β-1,3/1,6-glucan from Durvillaea Antarctica inhibits tumor progression in vivo as an immune stimulator
12. Boosting CO2 methanation activity on Ru/TiO2 catalysts by exposing (001) facets of anatase TiO2
13. Zelnorm, an agonist of 5-Hydroxytryptamine 4-receptor, acts as a potential antitumor drug by targeting JAK/STAT3 signaling
14. Integrated transcriptomic and metabolomic analysis reveals the metabolic programming of GM-CSF- and M-CSF- differentiated mouse macrophages
15. Bioactive compound C498-0670 alleviates LPS-induced sepsis via JAK/STAT and NFκB signaling pathways
16. Table S5 from Receptor Tyrosine Kinase Phosphorylation Pattern–Based Multidrug Combination Is an Effective Approach for Personalized Cancer Treatment
17. Data from Receptor Tyrosine Kinase Phosphorylation Pattern–Based Multidrug Combination Is an Effective Approach for Personalized Cancer Treatment
18. Figure S1 from Receptor Tyrosine Kinase Phosphorylation Pattern–Based Multidrug Combination Is an Effective Approach for Personalized Cancer Treatment
19. Supplementary from Receptor Tyrosine Kinase Phosphorylation Pattern–Based Multidrug Combination Is an Effective Approach for Personalized Cancer Treatment
20. STX5 Inhibits Hepatocellular Carcinoma Adhesion and Promotes Metastasis by Regulating the PI3K/mTOR Pathway
21. Effects of Residual Composition and Distribution on the Structural Characteristics of the Protein
22. The Culture Dish Surface Influences the Phenotype and Dissociation Strategy in Distinct Mouse Macrophage Populations
23. Identifying gene variants underlying the pathogenesis of diabetic retinopathy based on integrated genomic and transcriptomic analysis of clinical extreme phenotypes
24. Association Between Metabolic Syndrome and Risk of Renal Cell Cancer: A Meta-Analysis
25. The phagocytic receptors of β-glucan
26. Inhibition of Histone H3 Lysine-27 Demethylase Activity Relieves Rheumatoid Arthritis Symptoms via Repression of IL6 Transcription in Macrophages
27. C644‐0303, a small‐molecule inhibitor of the Wnt/β‐catenin pathway, suppresses colorectal cancer growth
28. Scaffold compound L971 exhibits anti‐inflammatory activities through inhibition of JAK/STAT and NFκB signalling pathways
29. Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer
30. A virus-induced conformational switch of STAT1-STAT2 dimers boosts antiviral defenses
31. Short-term exposure to air pollution and occurrence of emergency stroke in Chongqing, China
32. The influence of zinc loadings on the selectivity control of bio-ethanol transformation over MgO-SiO2 catalysts
33. Discovery and evaluation of Atopaxar hydrobromide, a novel JAK1 and JAK2 inhibitor, selectively induces apoptosis of cancer cells with constitutively activated STAT3
34. Support effect of Ag/ZnO catalysts for partial oxidation of methanol
35. Unfolded Protein Response Differentially Regulates TLR4-Induced Cytokine Expression in Distinct Macrophage Populations
36. Virtual Screening Guided Design, Synthesis and Bioactivity Study of Benzisoselenazolones (BISAs) on Inhibition of c-Met and Its Downstream Signalling Pathways
37. Zelnorm, an agonist of 5-Hydroxytryptamine 4-receptor, acts as a potential antitumor drug by targeting JAK/STAT3 signaling
38. Morphological control of inverted MgO-SiO2 composite catalysts for efficient conversion of ethanol to 1,3-butadiene
39. E2F is required for STAT3-mediated upregulation of cyclin B1 and Cdc2 expressions and contributes to G2–M phase transition
40. Discovery and evaluation of Atopaxar hydrobromide, a novel JAK1 and JAK2 inhibitor, selectively induces apoptosis of cancer cells with constitutively activated STAT3.
41. Synthesis of Biotinylated 2-methoxystypandrone and Identification of JAK2 and IKK as its Targets
42. Concomitant inhibition of receptor tyrosine kinases and downstream AKT synergistically inhibited growth of KRAS/BRAF mutant colorectal cancer cells
43. Receptor Tyrosine Kinase Phosphorylation Pattern–Based Multidrug Combination Is an Effective Approach for Personalized Cancer Treatment
44. Boosting CO2methanation activity on Ru/TiO2catalysts by exposing (001) facets of anatase TiO2
45. E2F is required for STAT3-mediated upregulation of cyclin B1 and Cdc2 expressions and contributes to G2–M phase transition.
46. A Novel Synthetic Analog of 5, 8-Disubstituted Quinazolines Blocks Mitosis and Induces Apoptosis of Tumor Cells by Inhibiting Microtubule Polymerization
47. Gp130-dependent STAT3 activation in M-CSF-derived macrophages exaggerates tumor progression.
48. Axl inhibitor R428 induces apoptosis of cancer cells by blocking lysosomal acidification and recycling independent of Axl inhibition.
49. Concomitant inhibition of receptor tyrosine kinases and downstream AKT synergistically inhibited growth of KRAS/BRAF mutant colorectal cancer cells.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.